Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2008
11/18/2008US7452685 Nucleotide sequences coding g-protein coupled receptors for identifying modulators of sweet taste transduction; sweetners and flavoring; tastands and food treatment
11/18/2008US7452684 Collagen XXII, a novel human collagen and uses thereof
11/18/2008US7452682 Identification of 5HT2A receptor ligands by selective amplification of cells transfected with receptors
11/18/2008US7452681 identifying markers indicative of the risk of developing a neurodevelopmental disorder caused in part by antibody- or autoantibody-mediated damage of neural tissue
11/18/2008US7452680 MCT1 transporters expressed in blood brain barrier cells
11/18/2008US7452679 Hybridization; phage display; spectroscopy
11/18/2008US7452678 biomarker polypeptides for determining if a test substance will cause hepatotoxicity; kits
11/18/2008US7452677 for the identification and isolation of chondrocytes, mesenchymal progenitor cells and embryonic stem cells for tissue engineering of cartilage; diseases related to joints, cartilage and atherosclerosis
11/18/2008US7452676 Monoclonal antibodies to RNA binding protein GW182
11/18/2008US7452675 Useful in identifying molecules, that bind TRPM4b (transmembrane channel polypeptides) which modulate TRPM4b ion channel activity, and/or which alter expression of TRPM4b within cells
11/18/2008US7452670 Methods of identifying agents that diminish cellular toxicity associated with an α-synuclein polypeptide of Parkinson's disease in yeast
11/18/2008US7452664 By determining the level of NAD-dependent acetylation and/or ADP ribosylation of a nuclear protein
11/18/2008US7452505 Aqueous solution containing surfactant; quantitative analysis
11/18/2008US7452457 System and method for analyte measurement using dose sufficiency electrodes
11/18/2008CA2500071C Multiple capillary sensor analysis system
11/18/2008CA2492740C Breath alcohol measuring device
11/18/2008CA2440399C Epitope testing using hla
11/18/2008CA2417556C Simple quantitative fluorescent assay method for determining the activity of transport proteins of interest
11/18/2008CA2386173C System and method of assessing the structural properties of wooden members using ultrasound
11/18/2008CA2373993C Site specific binding system, nuclear imaging compositions and methods
11/18/2008CA2341614C Prolonged storage of red blood cells
11/18/2008CA2331897C Multi-analyte diagnostic system and computer implemented process for same
11/18/2008CA2325137C Handheld sensing apparatus
11/18/2008CA2306752C Chemiluminescent reagent and chemiluminescent analysis using the same
11/18/2008CA2302245C Performance-based control system
11/18/2008CA2288234C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/18/2008CA2287781C Methods for measuring cellular proliferation and destruction rates in vitro and in vivo
11/18/2008CA2286183C Compositions and methods for inhibiting light-induced inactivation of biological reagents
11/18/2008CA2285647C Titration method for a complex viral composition
11/18/2008CA2285048C Analytical device for membrane-based assays
11/18/2008CA2275844C Specific binding assays using methyl orange
11/18/2008CA2224666C Assay methods and kits for diagnosing autoimmune disease
11/18/2008CA2223047C Micelle protection assay
11/18/2008CA2215042C Assay reagents and devices
11/18/2008CA2138594C Process for preparing clear sera which are stable over a long period
11/18/2008CA2133587C Compounds having selectivity for retinoid x receptors
11/18/2008CA2116239C Gene probe biosensor method
11/18/2008CA2095421C Novel amyloid precursor proteins and methods of using same
11/18/2008CA1341584C Method of amplifying and detecting nucleic acid sequences
11/13/2008WO2008137993A1 Compositions and methods for characterizing and regulating olfactory sensation
11/13/2008WO2008137991A1 Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
11/13/2008WO2008137930A1 TNFα GENE EXPRESSION AS A BIOMARKER OF SENSITIVITY TO ANTAGONISTS OF INHIBITOR OF APOPTOSIS PROTEINS
11/13/2008WO2008137910A2 Matrix stabilization of aggregation-based assays
11/13/2008WO2008137885A1 Elimination of interference in immunoassays caused by anti-carbohydrate antibodies
11/13/2008WO2008137881A2 Ehrlichia ewingii proteins, nucleic acids, and methods of their use
11/13/2008WO2008137865A2 Detecting isomers using differential derivatization mass spectrometry
11/13/2008WO2008137834A2 Crystal structure of smyd3 protein
11/13/2008WO2008137767A1 Tandem mass spectrometry for detecting and/or screening for conditions associated with altered sterols
11/13/2008WO2008137749A1 Diagnostic device and method for testing hydration and other conditions
11/13/2008WO2008137716A2 Subsystems and methods for use in patch clamp systems
11/13/2008WO2008137673A1 Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists
11/13/2008WO2008137629A2 Identifying germline competent embryonic stem cells
11/13/2008WO2008137604A1 Pyridinium boronic acid quenchers for use in analyte sensors
11/13/2008WO2008137600A1 Methods for measuring platelet reactivity of individuals treated with drug eluting stents
11/13/2008WO2008137591A2 Non-invasive detection of endometrial cancer
11/13/2008WO2008137586A1 Transcriptomic biomarkers for individual risk assessment in new onset heart failure
11/13/2008WO2008137549A2 Methods and compositions for diagnosing osteoarthritis in a feline
11/13/2008WO2008137533A1 Methods and compositions for upregulation of gata activity
11/13/2008WO2008137530A1 Methods of screening for binding interaction using sets of microparticles and unique probes
11/13/2008WO2008137504A1 Pharmaceutical analysis apparatus and method
11/13/2008WO2008137212A1 Piezo dispensing of a diagnostic liquid into microfluidic devices
11/13/2008WO2008137165A1 Anti-glycated cd59 antibodies and uses thereof
11/13/2008WO2008137120A1 Binding reagents that contain small epitope binding molecules
11/13/2008WO2008137075A2 Compositions and methods for the treatment of metabolic disorders and inflammation
11/13/2008WO2008136981A1 Reagent, system and method for nitrate analysis
11/13/2008WO2008136861A2 Inactivated and dried biological preparations
11/13/2008WO2008136772A1 Method of monitoring retinopathy
11/13/2008WO2008136769A1 Online contaminant detection and removal system
11/13/2008WO2008136735A1 Material for separation of a biomolecule
11/13/2008WO2008136734A1 Methods and systems for detecting biological and chemical materials on a submicron structured substrate
11/13/2008WO2008136675A1 Method and apparatus for preparing cheese from milk
11/13/2008WO2008136548A1 Device of measuring and monitoring a hemoglobin value through blood tube
11/13/2008WO2008136510A1 Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes
11/13/2008WO2008136473A1 Analysis instrument
11/13/2008WO2008136437A1 Measurement device
11/13/2008WO2008136273A1 Method for bilirubin determination and analytical instrument used for bilirubin determination
11/13/2008WO2008136067A1 Lumber inspection method, device and program
11/13/2008WO2008135977A1 Method of detecting infection with urogenital mycoplasmas in humans and a kit for diagnosing same
11/13/2008WO2008135955A1 Process for mixing and screening liquid compositions
11/13/2008WO2008135930A1 Sensor system based on compound with solubility depending on analyte concentration
11/13/2008WO2008135899A1 Bio-recognition sensor with actuation device
11/13/2008WO2008135862A2 Devices and methods for detecting analytes
11/13/2008WO2008135790A1 Biologically active c-terminal fragment of acetylcholinesterase
11/13/2008WO2008135771A1 Assay for detecting mycobacterial infection
11/13/2008WO2008135756A1 Peptide standards
11/13/2008WO2008135642A1 Method for determining a score representing the oxidative stress of a patient, on a scale of 0 to 10
11/13/2008WO2008135639A2 Novel useful inhibitors
11/13/2008WO2008135589A1 Polymorphic length of foxe1 alanine stretch and genetic susceptibility to thyroid dysgenesis
11/13/2008WO2008135571A1 Method for determining amino-terminal proanp in patients having a cardiac disease or being suspected of developing or having a cardiac disease
11/13/2008WO2008135553A1 Multi-immunoaffinity based antigen identification
11/13/2008WO2008135411A1 Method for predicting a physical property of a residue obtainable from a crude oil
11/13/2008WO2008135368A1 Device for the capacitive measurement of the quality and/or degradation of a fluid
11/13/2008WO2008135367A1 Device for the capacitive measurement of the quality and/or degradation of a fluid, including a capacitive sensor that is mechanically decoupled from the encapsulation element thereof
11/13/2008WO2008135274A2 Method for the detection of specific immunoglobulin class g antibodies
11/13/2008WO2008135239A1 PHARMACEUTICAL COMPOSITION FOR INCREASING INSULIN SECRETION FROM PANCREATIC β-CELLS
11/13/2008WO2008135067A1 Method for the diagnosis of tuberculosis
11/13/2008WO2008135038A2 DIAGNOSIS AND RISK STRATIFICATION USING NT-proET-1
11/13/2008WO2008134882A1 Methods and compositions for use of cyclic analogues of histatin
11/13/2008WO2008134881A1 Methods for the detection of preeclampsia
11/13/2008WO2008134878A1 Compositions and methods for cancer treatment
1 ... 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 ... 3937